期刊文献+

胆固醇酯转运蛋白及其基因多态性与2型糖尿病大血管病变的关系 被引量:6

The Relationship between Cholesteryl Ester Transfer Protein and Type 2 Diabetic Macroangiopathy in Chinese
在线阅读 下载PDF
导出
摘要 探讨胆固醇酯转运蛋白在 2型糖尿病大血管病变发生中所起的作用及胆固醇酯转运蛋白TaqⅠB基因多态性与大血管病变的关系。对 96例正常对照者及 2 2 6例 2型糖尿病患者的血清胆固醇酯转运蛋白水平及胆固醇酯转运蛋白TaqⅠB基因型进行研究。结果发现 :① 2型糖尿病组胆固醇酯转运蛋白水平较正常对照组明显升高 ,大血管病变组升高更显著 ;②糖尿病大血管病变组B1B1基因型频率 (37.3% )显著高于无大血管病变组(16 .4 % ) ,B1B1基因型大血管病变发生率 (6 8.3% )明显高于B1B2 (4 6 .6 % )和B2B2 (2 9.1% )型 ;③多元回归分析显示 ,高胆固醇酯转运蛋白水平和B1等位基因是 2型糖尿病大血管病变的危险因素。提示 :① 2型糖尿病患者血清胆固醇酯转运蛋白水平升高 ,后者是 2型糖尿病大血管病变的危险因素 ;②胆固醇酯转运蛋白TaqⅠB基因多态性与 2型糖尿病大血管病变发生有关 ,B1等位基因是 2型糖尿病大血管病变的易感基因。 Aim To investigate the association of cholesteryl ester transfer protein (CETP) and CETP TaqⅠB polymorphism with type 2 diabetic macroangiopathy in Chinese. Methods The level of serum CETP was measured by enzyme-linked immunosorbent assay (ELISA) and CETP genotype was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 96 healthy controls and 226 patients with type 2 diabetes mellitus. Results ①The serum level of CETP in type 2 diabetes groups was significantly higher than that in controls, and its level in patients with macroangiopathy was higher than that in patients without macroangiopathy. ②The frequency of genotype B1B1 (37.3%) in type 2 diabetes with macroangiopathy significantly higher than that in patients without macroangiopathy (16.4%). Compared with genotype B2B2 ( 29.1% ) class, the morbidity of macroangiopathy in genotype B1B1 (68.3%) or B1B2 (46.6%) class was significantly increased. ③Multiple logistic analysis showed that the serum CETP and its B1 allele were the important risk factors of type 2 diabetic macroangiopathy. Conclusions ①Serum CETP level rises in diabetic patients and high CETP level may be an important risk factor for type 2 diabetic macroangiopathy. ②CETP TaqⅠB polymorphism is associated with the development and progression of type 2 diabetic macroangiopathy. B1 allele may be a susceptible gene of type 2 diabetic macroangiopathy.
出处 《中国动脉硬化杂志》 CAS CSCD 2003年第6期549-552,共4页 Chinese Journal of Arteriosclerosis
关键词 胆固醇酯转运蛋白 2型糖尿病 大血管病变 聚合酶链反应-限制性片断长度多态性技术 动脉粥样硬化 基因多态性 酶联免疫吸附测定 Atherosclerosis Gene Polymorphism Enzyme-linked Immunosorbent Assay Type 2 Diabetes Mellitus Cholesteryl Ester Transfer Protein
  • 相关文献

参考文献13

  • 1李虎.胆固醇酯转运蛋白限制片长多态性与冠心病[J].中国动脉硬化杂志,2001,9(5):447-449. 被引量:2
  • 2[2]Rothblat GH, Llera-Moya M, Atger V, Weibel GK, Williams DL, Phillips MC. Cell cholesterol efflux;integration of old and new observations provides new insight. J Lipid Res, 1999, 40 (4): 781-796
  • 3[3]Bagdade JD, Wagner JD, Rudel LL, Clarkson TB. Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic cynomolgus monkeys. J Lipid Res, 1995, 36 (4): 759-766
  • 4[4]Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem, 1998, 273: 5 033-036
  • 5[5]Rittershaus CW, Miller DP, Thomas LJ, Picard MD, Honan CM, Emmett CD. Vaccine- induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol, 2000, 20: 2 106-112
  • 6[6]Grooth GJ, Kuivenhoven JA, Stalenhoef AF, Graaf J, Zwinderman AH,Posma JL. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation, 2002, 105 (18): 2 159-165
  • 7[7]Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol, 2001, 21 (2): 282-288
  • 8[8]Kawasaki I, Tahara H, Emoto M, Shoji T, Nishizawa YK. Relationship between TaqⅠB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes, 2002, 51 (3): 871-874
  • 9[9]Meguro S, Takei I, Murata M, Hirose H, Takei N, Mitsuyoshi Y. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis, 2001, 156 (1): 151-156
  • 10[10]Kuivenhoven JA, Jukema JW, Zwinderman AH, De Knijff P, McPherson R,Bruschke AV. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med, 1998, 338 (2): 86-93

二级参考文献6

共引文献3

同被引文献30

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部